Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1995 Aug;71(4):254–256. doi: 10.1136/sti.71.4.254

The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicentre, double blind, placebo controlled trial. B V Investigators Group.

I H Ahmed-Jushuf 1, M Shahmanesh 1, O P Arya 1
PMCID: PMC1195525  PMID: 7590720

Abstract

OBJECTIVE--To evaluate the efficacy and safety of a 3 day course of intravaginal clindamycin 2% cream for the treatment of bacterial vaginosis. DESIGN--A prospective, randomised, double-blind placebo controlled study. SETTING--Departments of genitourinary medicine at Birmingham, Nottingham, Liverpool, Swansea, Leeds, Walsall, Stoke Mandeville, Southampton, Plymouth, Bishop's Stortford and Glasgow. SUBJECTS--Pre-menopausal women aged 18 years and over, who had symptomatic bacterial vaginosis were randomly allocated to receive either clindamycin 2% cream 5 grams (107 patients) or matching placebo cream (114 patients), daily for three days. Response to therapy was assessed at 7 days (Visit 2) and 28 days (Visit 3). RESULTS--221 patients with symptomatic bacterial vaginosis were enrolled to the study and of these 141 (63.8%) completed the study. On the "intent-to-treat" (ITT) analysis, 75% of the clindamycin group were classified as "success" or "improved" at visit 2 compared with 13% of the placebo group (p < 0.001). At Visit 3, 41% of the clindamycin group were classified as either "success" or "improved" versus 4% in the placebo group (p < 0.001). Of the 80 patients who were recorded "success" or "improved" at visit 2, 20 (25%) were reported to have a "recurrence" of BV at Visit 3. The meta-analysis on those who were evaluable at Visit 2 and 3 also showed that clindamycin cream 2% was an effective treatment for bacterial vaginosis, and the differences between the clindamycin group and the placebo group were statistically significant. CONCLUSION--We conclude that a 3 day course of clindamycin 2% cream is an effective, and well tolerated treatment for bacterial vaginosis.

Full text

PDF
254

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackwell A. L., Fox A. R., Phillips I., Barlow D. Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet. 1983 Dec 17;2(8364):1379–1382. doi: 10.1016/s0140-6736(83)90920-0. [DOI] [PubMed] [Google Scholar]
  2. Dhar J., Arya O. P., Timmins D. J., Moss S., Mukembo S., Alawattegama A. B., Williams O. Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study. Genitourin Med. 1994 Apr;70(2):121–123. doi: 10.1136/sti.70.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eschenbach D. A., Critchlow C. W., Watkins H., Smith K., Spiegel C. A., Chen K. C., Holmes K. K. A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis Suppl. 1983;40:73–80. [PubMed] [Google Scholar]
  4. Greaves W. L., Chungafung J., Morris B., Haile A., Townsend J. L. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol. 1988 Nov;72(5):799–802. [PubMed] [Google Scholar]
  5. Hay P. E., Taylor-Robinson D., Lamont R. F. Diagnosis of bacterial vaginosis in a gynaecology clinic. Br J Obstet Gynaecol. 1992 Jan;99(1):63–66. doi: 10.1111/j.1471-0528.1992.tb14395.x. [DOI] [PubMed] [Google Scholar]
  6. Hillier S., Krohn M. A., Watts D. H., Wolner-Hanssen P., Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol. 1990 Sep;76(3 Pt 1):407–413. [PubMed] [Google Scholar]
  7. Livengood C. H., 3rd, Thomason J. L., Hill G. B. Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol. 1990 Jul;76(1):118–123. [PubMed] [Google Scholar]
  8. Pheifer T. A., Forsyth P. S., Durfee M. A., Pollock H. M., Holmes K. K. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978 Jun 29;298(26):1429–1434. doi: 10.1056/NEJM197806292982601. [DOI] [PubMed] [Google Scholar]
  9. Schmitt C., Sobel J. D., Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol. 1992 Jun;79(6):1020–1023. [PubMed] [Google Scholar]
  10. Swedberg J., Steiner J. F., Deiss F., Steiner S., Driggers D. A. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA. 1985 Aug 23;254(8):1046–1049. [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES